IsoRay gains $4.3 million in financing agreement

IsoRay, Inc., a Richland-based developer of cancer therapies, has announced a securities purchase agreement with an investor to sell $2.25 million in common stock with the potential of $2,075,000 in additional funding. IsoRay plans to use net proceeds from the financing on several fronts including support of the company’s catheter device used in treating brain cancer.

Read the IsoRay press release

Advertisements
This entry was posted in Company_and_Client_News, IsoRay. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s